Future Oncology, Volume 17, Issue 1 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Future Oncology, Volume 17, Issue 1 (2021)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Volume 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Foreword

Introduction
Past, Present and Future Oncology: Welcome to Volume 17
Louis Gautier
Pages: 1-5
Published online: 06 Jan 2021
First Page PreviewforPast, Present and Future Oncology: Welcome to Volume 17 | Full Text | References | PDF (1.4 MB) | EPUB
  • 1134 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Letter to the Editor

Letter to the Editor
Incorporating Teleoncology Practices in the Undergraduate Medical Curriculum
Anna Maria Wozniak & Kathrine Sofia Rallis
Pages: 7-9
Published online: 01 Nov 2020
First Page PreviewforIncorporating Teleoncology Practices in the Undergraduate Medical Curriculum | Full Text | References | PDF (1.2 MB) | EPUB
  • 1317 Views
  • 1 CrossRef citations
  • 0Altmetric

Letter in Reply

Reply
In Reply to: Incorporating Teleoncology Practices in the Undergraduate Medical Curriculum
Ronaldo Elkaddoum, Fady Gh Haddad, Roland Eid & Hampig Raphael Kourie
Pages: 11-12
Published online: 27 Nov 2020
CitationforIn Reply to: Incorporating Teleoncology Practices in the Undergraduate Medical Curriculum | Full Text | References | PDF (1.2 MB) | EPUB
  • 658 Views
  • 0 CrossRef citations
  • 0Altmetric

Drug Evaluation

Review Article
Alpelisib in the Treatment of Metastatic HR+ Breast Cancer with PIK3CA Mutations
Athanasios Mavratzas & Frederik Marmé
Pages: 13-36
Published online: 23 Sep 2020
AbstractforAlpelisib in the Treatment of Metastatic HR+ Breast Cancer with PIK3CA Mutations | Full Text | References | PDF (2 MB) | EPUB
  • 699 Views
  • 0 CrossRef citations
  • 0Altmetric

Preliminary Communication

Brief Report
Development and Validation of the Therapy Preference Scale to Understand Patients´ Systemic Cancer Treatmentpreferences
Vijaya Raj Bhatt, Prajwal Dhakal, Christopher S Wichman & Bunny Pozehl
Pages: 37-44
Published online: 02 Dec 2020
AbstractforDevelopment and Validation of the Therapy Preference Scale to Understand Patients´ Systemic Cancer Treatmentpreferences | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 70 Views
  • 0 CrossRef citations
  • 0Altmetric

Research Article

Article
Toxicities of Axitinib, Sunitinib and Temsirolimus: Implications for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer
Annemarie Uhlig, Johannes Uhlig, Lutz Trojan, Michael Woike, Marianne Leitsmann & Arne Strauß
Pages: 45-56
Published online: 04 Dec 2020
AbstractforToxicities of Axitinib, Sunitinib and Temsirolimus: Implications for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 174 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Transcription Factor STAT1 Promotes the Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells by Upregulating LINC01160
Jingang Ai, Guolin Tan, Tiansheng Wang, Wei Li, Ru Gao, Yexun Song, Shanshan Xiong & Xiang Qing
Pages: 57-69
Published online: 02 Dec 2020
AbstractforTranscription Factor STAT1 Promotes the Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells by Upregulating LINC01160 | Full Text | References | PDF (10.9 MB) | EPUB
  • 188 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Metabolic Gene Signature for Predicting Breast Cancer Recurrence Using Transcriptome Analysis
Juan Feng, Jun Ren, Qingfeng Yang, Lingxia Liao, Le Cui, Yiping Gong & Shengrong Sun
Pages: 71-80
Published online: 05 Jan 2021
AbstractforMetabolic Gene Signature for Predicting Breast Cancer Recurrence Using Transcriptome Analysis | Full Text | References | PDF (2.2 MB) | EPUB
  • 201 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Liquid Biopsy for ALK-Positive Early Non-Small-Cell Lung Cancer Predicts Disease Relapse
Ji Li, Wen Dong, Li Na Liu, Yi Jiang Huang & Mei Fang Xiao
Pages: 81-90
Published online: 29 Sep 2020
AbstractforLiquid Biopsy for ALK-Positive Early Non-Small-Cell Lung Cancer Predicts Disease Relapse | Full Text | References | PDF (2.2 MB) | EPUB
  • 228 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Cabazitaxel Schedules in Metastatic Castration-Resistant Prostate Cancer: A Review
Cedric Pobel, Edouard Auclin, Adrien Procureur, Alice Clément-Zhao, Audrey Simonaggio, Nicolas Delanoy, Yann-Alexandre Vano, Constance Thibault & Stéphane Oudard
Pages: 91-102
Published online: 02 Dec 2020
AbstractforCabazitaxel Schedules in Metastatic Castration-Resistant Prostate Cancer: A Review | Full Text | References | PDF (1.4 MB) | EPUB
  • 325 Views
  • 0 CrossRef citations
  • 0Altmetric

Meta Analysis

Article
Indirect Analysis of First-Line Therapy for Advanced Non-Small-Cell Lung Cancer with Activating Mutations in a Japanese Population
Kazuhiko Nakagawa, Koichi Matsumura, Tayler Scory, Megan S Farris, Kelly A Larkin-Kaiser, Hironori Kikkawa, Jasmina I Ivanova & Keith D Wilner
Pages: 103-115
Published online: 22 Sep 2020
AbstractforIndirect Analysis of First-Line Therapy for Advanced Non-Small-Cell Lung Cancer with Activating Mutations in a Japanese Population | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 1688 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access

Corrigendum

Correction
Corrigendum
Page: 117
Published online: 07 Dec 2020
CitationforCorrigendum | Full Text | PDF (1.2 MB) | EPUB
  • 171 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe
Jingchuan Zhang et al.
Rapid Communication | Published online: 9 Aug 2024
Open Access
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain
Isabel Blancas et al.
Rapid Communication | Published online: 8 Aug 2024
Open Access
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
James J Harding et al.
Plain Language Summary of Publication | Published online: 8 Aug 2024
Open Access
Plain language summary of the CARTITUDE-4 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
Jesús San-Miguel et al.
Plain Language Summary of Publication | Published online: 7 Aug 2024
Open Access
View all latest articles